Steven Katz is the President of Steven Katz & Associates, Inc., a health care and technology-based management consulting firm specializing in strategic planning, corporate development, new product planning, technology licensing, and structuring and securing various forms of financing. Mr. Katz has been President of Steven Katz & Associates, Inc. since 1982. From January 2000 to October 2001 Mr. Katz was also President, Chief Operating Officer and a director of Senesco Technologies, Inc., (AMEX: SNT), a company engaged in the identification and development of proprietary gene technology with application to human, animal and plant systems. From 1983 to 1984 he was a co-founder and Executive Vice President of S.K.Y. Polymers, Inc., a bio-materials company. Prior to this, Mr. Katz was Vice President and General Manager of a non-banking division of Citicorp. From 1976 to 1981 he held various senior management positions at National Patent Development Corporation, including President of three subsidiaries. Prior positions were with Revlon, Inc. (1975) and Price Waterhouse & Co. (1969 to 1974). Mr. Katz received a Bachelors of Business Administration degree in Accounting from the City College of New York in 1969. He is presently a member of the Boards of Directors of a number of publicly-held corporations, including Biophan Technologies, Inc. (OTCBB: BIPH), Health Systems Solutions, Inc. (OTCBB:HSLN), NanoScience Technologies, Inc. (OTCBB: NANS), USA Technologies (OTCBB:USTT), and several companies in registration to go public including IbuyDigital.com, Inc., and Vivid Learning Systems, Inc.

View the personal profiles and accomplishments of Infinity Capital.


Management

Gregory H. Laborde | Chairman & CEO

Theodore A. Greenberg | Chief Investment Officer, CFO, Director

Steven Katz | SR VP Business Development, Director


Disinterested Directors

Pierce McNally, Director

Conrad Huss, Director

Ernest D. Chu, Director

John Maroney, Director